Overview

Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine safety and tolerability of daily tenofovir use in HIV-uninfected men.
Phase:
Phase 2
Details
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborators:
AIDS Research Consortium of Atlanta
San Francisco Department of Public Health
Treatments:
Tenofovir